 3D bioprinting is a promising new technology that has the potential to revolutionize the field of tissue engineering. It allows for the precise layering of cells, biologic scaffolds, and growth factors to create bio-identical tissue for a variety of uses. Early successes have shown that 3D bioprinting can be used to produce tissues that mimic those found in nature, which could lead to improved treatments for diseases such as cancer or diabetes. However, there are still many challenges to overcome before 3D bioprinting can become clinically relevant. These include the need for better control of cellular behavior, the development of more sophisticated biomaterials, and the ability to accurately monitor and regulate the process. Despite these hurdles, 3D bioprinting holds great promise for the future of personalized medicine. This article was authored by Elliot S. Bishop, Sammy Mostafa, Mikhail Pakvesa, and others.